{
  "report_rows": [
    {
      "kpi": "Q2 2026 revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$14.58B vs. cons $14.48B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.70 vs. cons $0.68",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 Padcev revenue",
      "prediction": "BEAT",
      "answer": "pred ~$0.68B vs. cons $0.66B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Full-year revenue guidance midpoint",
      "prediction": "UNCHANGED",
      "answer": "guide ~$61.0B vs. cons $61.8B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Full-year adjusted diluted EPS guidance midpoint",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.90 vs. cons $2.96 (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 1.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.3,
  "day5_path": "FADE",
  "day5_rationale": "A modest Q2 EPS beat supports the initial reaction, but unchanged FY2026 guidance at a ~$2.90 EPS midpoint versus $2.96 consensus and ~$61.0B revenue midpoint versus $61.8B consensus limits estimate revisions; the implied second-half revenue requirement remains roughly $32.0B versus Street math near $32.8B.",
  "day5_confidence": "MEDIUM"
}